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RESEARCH ARTICLE Open Access
Induction techniques that reduce
redistribution hypothermia: a prospective,
randomized, controlled, single blind
effectiveness study
Jonathan V. Roth1,2,3* , Leonard E. Braitman4 and Lacy H. Hunt4
Abstract
Background: While much effort has been devoted to correcting intraoperative hypothermia, less attention has
been directed to preventing redistribution hypothermia. In this study, we compared three different anesthetic
induction techniques to standard IV propofol inductions (control) in their effect on reducing redistribution
hypothermia.
Methods: Elective, afebrile patients, age 18 to 55 years, were randomly assigned to one of four groups (n = 50
each). Group “INH/100” was induced with 8% sevoflurane in 100% oxygen, Group “INH/50” with 8% sevoflurane in
50% oxygen and 50% nitrous oxide, Group “PROP” with 2.2 mg/kg propofol, and Group “Phnl/PROP” with 2.2 mg/kg
propofol immediately preceded by 160 mcg phenylephrine. Patients were maintained with sevoflurane in 50%
nitrous oxide and 50% oxygen in addition to opioid narcotic. Forced air warming was used. Core temperatures
were recorded every 15 min after induction for 1 h.
Results: Compared to control group PROP, the mean temperatures in groups INH/100, INH/50, and Phnl/PROP
were higher 15, 30, 45 and 60 min after induction (p < 0.001 for all comparisons), averaging between 0.39 °C and
0.54 °C higher. In group PROP, 60% of patients had at least one temperature below 36.0 °C in the first hour whereas
only 16% did in each of groups INH/100, INH/50, and Phnl/PROP (p < 0.0001 in each group compared to PROP).
Conclusions: In this effectiveness trial, inhalation inductions with sevoflurane or with prophylactic phenylephrine
bolus prior to propofol induction reduced the magnitude of redistribution hypothermia by an average of 0.4 to
0.5 °C in patients aged 18 to 55 years.
Trial registration: Retrospectively registered on clinical-trials.gov as NCT02331108, November 20, 2014.
Keywords: Hypothermia, Redistribution hypothermia, Intraoperative hypothermia, Perioperative hypothermia,
Postoperative hypothermia, Anesthesia induction, Inhalation induction, Intravenous induction, Inhalation anesthesia
induction, Intravenous anesthesia induction
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What we already know about this topic
Propofol causes significant redistribution hypothermia,
and intraoperative hypothermia is common in the first
hour of anesthesia.
What this article tells us that is new
Either inhalation inductions with sevoflurane or the ad-
ministration of phenylephrine immediately prior to
intravenous induction with propofol can reduce the de-
gree of redistribution hypothermia by an average of 0.4
to 0.5 °C during the first hour of anesthesia. The degree
and duration of intraoperative hypothermia can be re-
duced by using these alternative induction techniques.
Background
Hypothermia has multiple adverse consequences and
should be avoided [1, 2]. Anesthesia induction with propo-
fol is known to cause a rapid and clinically important
temperature decrease due to redistribution hypothermia,
typically by about 1.5 °C [3]. Ikeda et al. showed there is on
average 0.7 °C less redistribution hypothermia when pa-
tients are induced with an inhalation induction rather than
with intravenous propofol [3]. However, the use of inhal-
ation inductions has not been widely adapted. Sun et al.
documented that hypothermia is routine during the first
hour of anesthesia [4]. While there is great effort expended
to warm patients intraoperatively, relatively little attention
has been directed to preventing redistribution hypothermia.
In studies assessing whether patients were hypothermic,
two methods have been used. First, the “end of case”
temperature has been used to assess hypothermia and its
association with complications [5]. In the United States, the
SCIP (Surgical Care Improvement Project) guideline for
body temperature management uses end of case
temperature as its measure of compliance [5]. However,
this method has limitations in assessing intraoperative
hypothermia. Some hypothermia complications occur
intra-operatively (e.g., coagulopathy, increased transfusion
requirements), some post-operatively (e.g., shivering, de-
layed emergence) and some likely both (e.g., infection risk)
[4, 6, 7]. End of case hypothermia indicates intraoperative
hypothermia. End of case normothermia does not imply in-
traoperative normothermia. A patient may have been
hypothermic intraoperatively, having suffered the conse-
quences of intraoperative hypothermia, achieving normo-
thermia only at the end of the case. Thus, the contribution
of intraoperative hypothermia to postoperative complica-
tions may be unrecognized.
Because of the limitations of using end of case
temperature as an indication of intraoperative hypothermia,
more current literature focuses on the area under the core
temperature vs time curve. The magnitude of the area under
the time vs core temperature curve below a threshold, typic-
ally 36.0 °C, is used as an indicator of the degree of
hypothermia. The greater the area under 36.0 °C, the greater
the amount of intraoperative hypothermia. It is plausible
that if redistribution hypothermia can be reduced, there will
be less intraoperative hypothermia (assessed by less area
under the curve) and thus fewer intraoperative and postop-
erative complications associated with hypothermia.
Vasodilation causes redistribution hypothermia by in-
creasing blood flow to the cooler peripheral and dermal
thermal compartments. This results in heat transfer
away from the warmer core. We hypothesized that
anesthetic inductions causing less vasodilation (than
propofol alone inductions) will result in less redistribu-
tion hypothermia. The purpose of this effectiveness
study is to compare the effect of three such alternative
induction techniques to standard propofol inductions on
core temperature during the first hour of anesthesia.
Methods
This study and consent forms were approved by our IRB
(Albert Einstein Healthcare Network IRB #1) and submitted
to clinical-trials.gov as NCT02331108 by Jonathan V. Roth
on November 20, 2014. Written informed consent was ob-
tained by the first author from all participating patients.
(The consents were all dated and timed and signed by the
patient and the first author. A copy of the consent was pro-
vided to the patient. The original signed consent was main-
tained in the research file.) The manuscript complies with
the CONSORT requirements. This study was performed at
the Albert Einstein Healthcare Network in Philadelphia,
Pennsylvania during 2014 and 2015.
Four groups (described below and summarized in Table 3
in Appendix 1) of 50 patients each were studied. The major
inclusion criteria were: age 18 to 55 years inclusive; supine or
lithotomy positioning; scheduled for general anesthesia
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where 50% nitrous oxide would be used; endotracheal intub-
ation or laryngeal mask airway insertion would be used;
afebrile (preoperative oral or temporal scan temperature be-
tween 36.2 and 37.4 °C inclusive); forced air warming would
be used; and expected duration of anesthetic to be at least
60min. A complete list of inclusion and exclusion criteria
are presented in Table 4 in Appendix 2. After enrollment,
random assignments were contained in opaque envelopes
that were opened immediately before induction of anesthesia.
Each of the envelopes contained one of the four group desig-
nations, 50 envelopes for each group. Randomization was
achieved by putting the envelopes in a basket and mechanic-
ally mixing the envelopes within the basket. When a patient
was entered into the study, an opaque envelope was selected
arbitrarily from any location in the stack.
For all patients, operating rooms were kept between
21 °C and 24 °C with a target of 22 °C. No patients
were prewarmed. Upon entering the operating room,
cotton blankets were placed on all patients covering
their lower extremities, abdomen, and thorax. These
blankets were removed after induction to allow for
forced air warming (FAW) blanket placement and
surgical positioning, preparation, and draping. All op-
erating rooms had the same air flow design. Patients
were administered 2 mg IV midazolam prior to enter-
ing the operating room. No opioid narcotics were ad-
ministered until after the airway was secured with
either a laryngeal mask airway (LMA) or endotracheal
tube. Heat and moisture exchangers were used on all
patients. Patients could receive up to 300 mL room
temperature intravenous crystalloid before fluid was
warmed (Ranger, Arizant Healthcare, Eden Prairie,
MN) to 41 °C. All inductions, nasal temperature probe
placement, and application of a FAW blanket were
performed in the same manner by the first author.
(Nasal temperature was used as a surrogate for core
temperature for all patients since it could be used for
patients having either an LMA or endotracheal intub-
ation [8].) Either an upper or lower body FAW blan-
ket (SW-2010 Snuggle Warm Small Upper Body
Convective Warming Blanket, or SW-2001 Snuggle
Warm Adult Full Body Convective Warming Blanket,
Level 1, Smiths Medical ASD, Rockland, MA) was
used. The face was not directly covered by the FAW
blanket in order to avoid the possibility that a collec-
tion of warm air could affect the nasal temperature
measurements. Cotton blankets were placed on top of
the warming blankets. The FAW (Equator Convective
Warmer, Level 1, Smiths Medical ASD, Rockland,
MA) was turned on to 44 °C as soon as the patient
was prepped and draped; the time duration from the
start of induction (T0) until the time the FAW was
turned on was recorded. Neurophysiologic monitors
to measure “depth of anesthesia” were not used. Pre-
induction core temperatures were not measured. All
doses of propofol were based on actual (not ideal)
body weight.
Group INH/100 – inhalation induction with sevoflurane in
100% oxygen (O2)
A baseline blood pressure was taken prior to induction. No
formal preoxygenation regimen was performed. The patients
were asked to breath for a few breaths via the face mask
with 100% O2 just to confirm reservoir bag movement and
capnograph detection of carbon dioxide. At time T0, with
an unprimed circuit, the O2 flow meter was set at 6 LPM
and the sevoflurane vaporizer was turned on at 8%. Blood
pressures were recorded every minute starting 1 min after
T0 (T1) until airway intervention commenced. At the discre-
tion of the first author, an LMA was inserted when the pa-
tient was assessed to be adequately deep, determined by
masseter muscle relaxation, typically just 2 min after T0
(T2). Alternatively, if the patient was to be endotracheally
intubated, muscle relaxant (vecuronium, rocuronium, or
succinylcholine) was administered when the patient was
assessed as being unconscious, typically at T1. Positive pres-
sure ventilation was performed as required until endo-
tracheal intubation. If necessary, to avoid hypotension, the
Sevoflurane concentration was decreased while waiting for
adequate muscle relaxation. If the systolic blood pressure
dropped below 85mmHg prior to airway intervention, the
patient would be treated immediately either with phenyleph-
rine or airway intervention if ready. After securing either the
LMA or endotracheal tube, anesthesia was maintained with
sevoflurane in 50% nitrous oxide (1 LPM) and 50% O2 (1
LPM). Opioid narcotics (fentanyl, hydromorphone, metha-
done), neuromuscular reversal agents (glycopyrrolate, neo-
stigmine), dexamethasone, and ketamine were administered
as per the discretion of the attending anesthesiologist.
A skin temperature probe (Skin Temperature Sensor, 400
Series, DeRoyal Industries, Inc., Lane Powell, TN) was modi-
fied by removing the skin adhesive portion, bending the
probe 90° 8 cm from the tip (to assure insertion depth would
be 8 cm), and straightening the probe from the bend to the
tip. Previous work has shown a close agreement between
the nasal technique used in this study and distal esophageal
temperature measurements [8]. Within 10min of T0, the
blunt tipped nasal temperature probe was inserted 8 cm into
one naris [8–10]. This provided a minimum of 5min for
thermal equilibration of the temperature probe before the
first measurement (T15), 15 min after T0. Either naris was
used arbitrarily. Starting at T15, nasal temperatures were re-
corded every 15min (T15, T30, T45, T60). If the core
temperature reached 37.5 °C, the FAW was turned off. The
patient’s data were included in the analysis if there were at
least two temperature measurements (T15 and T30). If the
anesthetic ended before 30min or if there was a protocol
violation, that patient’s data were not analyzed; a
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replacement envelope assigning another future patient to
that group was generated and inserted randomly back into
the envelope stack. All patients received 4mg ondansetron
within 15min of emergence. Temperature data collection
ceased at the initiation of IV acetaminophen administration
or if there was any event that could have a substantial im-
pact on patient temperature. All cystoscopy procedures were
conducted with warmed bladder irrigation.
Group INH/50 - inhalation induction with sevoflurane in
50% nitrous oxide (N2O) / 50% O2
The protocol was identical to group INH/100 except that
induction was performed with 3 LPM N2O and 3 LPM O2
(instead of 6 LPM O2) with 8% sevoflurane.
Group PROP – intravenous induction with 2.2 mg/kg
intravenous propofol
The induction differed from group INH/100 in the following
manner. Two mL of 2% lidocaine (40mg) were added to 20
mL of 1% propofol. After preoxygenation with 100% O2 for
a minimum of 2min, 3 mL of 2% lidocaine (60mg) was ad-
ministered followed immediately by 2.2mg/kg propofol
(rounded to the nearest 5mg) at T0. If the patient was to re-
ceive an LMA, one blood pressure was taken at T1 and then
the LMA was inserted. If the patient was to be endotrache-
ally intubated, muscle relaxant was administered immedi-
ately after propofol administration, blood pressures were
measured every minute, and positive pressure ventilation
with 100% O2 was performed as required. After securing the
airway, the protocol continued in the same manner as in
Group INH/100.
Group Phnl/PROP – intravenous induction with 2.2 mg/kg
intravenous propofol preceded by 160 mcg
phenylephrine
The protocol differed from group PROP only in that 2
mL of 80 mcg/mL phenylephrine (160 mcg) was admin-
istered immediately after the administration of 3 mL 2%
lidocaine but before the 2.2 mg/kg propofol.
Statistical methods
To address the lack of pre-test core temperature measure-
ments, we used the post-test only, single blind randomized
trial. This is a “true experimental design” [11]. The primary
Fig. 1 Consort Diagram. Eleven patients consented but were never randomized and not studied: 9: The first author was not available to
perform the induction. 1: The case changed from a general anesthetic to a sedation case. 1: The surgeon did not want that patient to
be in a clinical study. Five patients were induced and then withdrawn from analysis* because of protocol violations: 1: Airway difficulty
during induction. 1: Additional propofol required; 2: Patients received more than 300mL unwarmed IV fluid. 1: Forced air warming malfunction.
*Four patients were withdrawn before T15 so that they had no post-induction temperature measurements. In one patient, there was only
one temperature measurement at T15. This patient received more than 300 mL unwarmed IV fluid
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outcomes were the nasal (core) temperatures at 4 time
points after induction (not changes from pre-induction
baseline). In bivariate analyses, we compared differences in
mean core temperature between the propofol only induction
control group (PROP) and each of 3 groups administered al-
ternative induction techniques (INH/100, INH/50, and
Phnl/PROP). Specifically, analyses of the mean temperature
differences (and 95%CIs) for 1) INH/100 vs. PROP, 2) INH/
50 vs. PROP, and 3) Phnl/PROP vs. PROP were performed
at each of 15, 30, 45, and 60min (T15, T30, T45, and T60)
after induction. These differences in mean core tempera-
tures at T15, T30, T45, and T60 among groups were assessed
using unpaired t-tests and corresponding 95% confidence
intervals (95% CIs). Bonferroni’s correction was used to ad-
just for these 12 multiple comparisons. Core temperature
data were tested for normality by the Shapiro-Wilk test.
The random assignment of 50 patients per group made it
likely that the treatment groups would be balanced in both
measured and unmeasured characteristics (including pre-
induction core temperatures). However, imbalances did
occur in BMI and sex. Those imbalances and the lack of
pre-induction core temperature measurements necessitated
a multivariable analysis comparing the average core tem-
peratures at T15, T30, T45, and T60; the covariates were
BMI, sex, age, ASA classification, and time to initiating
FAW. (Upper vs lower FAW were not covariates because
the rates of heat transfers are similar [12].) This multivari-
able analysis was a linear mixed model with random inter-
cepts and random slopes and unstructured covariance. This
model fit better than a model with random intercepts alone
nested within it (p < 0.0001 by the likelihood ratio test) [13].
There was no statistically significant interaction between
group and time (p = 0.15). Since the results of the bivariate
and multivariable analyses were similar and led to the same
conclusions, we present the simpler bivariate results. The
differences in the secondary outcomes, the percentages of
patients who had at least one temperature < 36.0 °C (and ≤
35.5 °C) between the control group (PROP) and each of the
other three groups were evaluated by Fisher’s exact tests.
Although the resulting p values were exact; the correspond-
ing 95% CIs were approximate.
Interval estimates of the percentages of patients that de-
veloped hypotension requiring treatment and of patients
undergoing an inhalation induction who developed apnea
were computed using exact binomial 95% CIs.
In a statistical power analysis, assuming alpha = 0.05 and
beta = 0.2, 17 patients per group were needed to detect a
0.5 °C difference between means of any two compared
groups as statistically significant in a two tailed test. We en-
rolled patients who were expected to have a surgical proced-
ure lasting at least 60min after the induction of anesthesia.
However, we had no way to estimate the percentage of cases
that would end early and therefore not provide data at T45
and T60. We increased the size of the study groups to 50 in
order to be reasonably sure there were at least 17 patients in
all groups at T60.
All statistical analyses compared patients as treated using
two-sided tests with alpha = 0.05 and were performed using
Stata, version 14 (Stata Press, College Station, Texas).
Results
After randomization and withdrawals, 50 patients in each
group were analyzed (Fig. 1). Demographic and forced air
warming data are presented in Table 1. The surgical pro-
cedures are presented in Table 5 Appendix 3.
Compared to group PROP, the three alternative induc-
tion groups each had higher mean core temperatures
and fewer patients having at least one core temperature
measurement < 36.0 °C in the first hour. At all four time
points (T15, T30, T45, T60), the mean temperatures in
group PROP were between 0.39 and 0.54 °C lower than
in groups INH/100, INH/50 and Phnl/PROP (all p ≤
0.0042 adjusted for multiple comparisons, Fig. 2,
Table 1 Demographics and forced air warming data of the 200
patients analyzed
Group INH/100 INH/50 PROP Phnl/PROP
Age (years)
Mean (SD) 42.8 (10.1) 43.0 (8.6) 39.0 (11.2) 40.6 (9.1)
Range 22 to 55 26 to 55 18 to 55 20 to 55
Sex
Male n(%) 20 (40) 31 (62) 20 (40) 21 (42)
ASA classification
1 n (%) 1 (2) 3 (6) 10 (20) 2 (4)
2 n (%) 23 (46) 23 (46) 29 (58) 33 (66)
3 n (%) 16 (52) 24 (48) 11 (22) 15 (30)
BMI (kg/m2)
Mean (SD) 31.9 (7.5) 31.2 (6.7) 26.8 (5.6) 29.9 (6.4)
Range 21.7 to 48.9 18.9 to 44.2 17.2 to 43.0 15.1 to 44.4
Preoperative
screening
temperature (°C)
Mean (SD) 36.8 (0.3) 36.8 (0.3) 36.8 (0.3) 36.7 (0.3)
Use of upper
body forced
air warming
(FAW) blanket
(remaining patients
used lower body FAW)
n 32 39 29 30
(%) (64) (78) (58) (60)
Time from T0
until FAW turned
on, (minutes)
Mean (SD) 16.4 (7.0) 14.7 (7.0) 15.9 (7.9) 17.1 (7.7)
Range 5 to 45 4 to 45 4 to 44 6 to 40
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Table 2). There were no statistically significant differ-
ences in the mean temperatures between groups INH/
100 and INH/50, INH/100 and Phyl/PROP, and INH/50
and Phyl/PROP at any time point (all p > 0.18). In group
PROP, 60% of patients had at least one temperature <
36.0 °C in the first hour compared to 16% in each of
groups INH/100, INH/50, and Phnl/PROP (all with an
identical 44 percentage point difference, 95% CI 27% to
61%, p < 0.0001). In group PROP, 22% of patients had at
least one temperature ≤ 35.5 °C, compared to 8% in
group INH/100 (p = 0.09), 4% in INH/50 (p = 0.015), and
2% in Phnl/PROP (p = 0.004).
No patient in any of these 4 groups had a core
temperature > 37.5 °C at any time point. Apnea did not
occur in either group INH/100 or INH/50 (0%, 95% CI
0% to 7.1% for each group).
Only blood pressures at T1 (and T2 if prior to airway
intervention) were considered. In the first 2 min, treat-
ment of hypotension (systolic BP < 85mmHg) was re-
quired in 2 patients in Group PROP (4%, 95% CI 0.5% to
13.7%) and 1 patient in group Phnl/PROP (2%, 95% CI
0.05% to 10.6%). In group Phnl/PROP, only 1 patient’s
blood pressure increased to a value > 180mmHg and no
patient suffered a reflex bradycardia ≤40 beats per minute.
No patients in groups INH/100 or INH/50 (0%, 95% CI 0%
to 7.1% for each group) required treatment for hypotension.
Discussion
This effectiveness study found that in patients aged 18
to 55 years, inhalation inductions with sevoflurane or the
administration of 160 mcg phenylephrine immediately
prior to 2.2 mg/kg propofol each caused less
Fig. 2 Mean Temperature ± SD and Number (n) in Each Group at Each Time Point (°C). In the three successive time intervals (T15 to T30, T30 to T45,
and T45 to T60), the percentage of patients (all groups combined) whose temperature decreased were (37.5, 14.4, and 14.2% respectively). The
percentage of patients whose temperature increased were (39.0, 55.4, and 59.1% respectively). The remaining patients had no temperature
changes within these time intervals
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redistribution hypothermia than intravenous inductions
with propofol alone.
This study’s results are consistent with previous
work [3, 4] and thus provide support for this study’s
conclusion. Ikeda found a 0.7 °C average thermal ad-
vantage of sevoflurane inhalation inductions over
intravenous propofol [3]. We found a slightly smaller
(0.4 °C to 0.5°) advantage. That may reflect the use of
forced air warming whereas Ikeda did not use FAW
[3]. Also, Ikeda used a larger dose of propofol, which
might have caused more vasodilation and thus more
redistribution hypothermia. Sun found 64% of 58,814
patients had a temperature < 36 °C after 45 min, close
to the 60% in group PROP; 29% were < 35.5 °C, close
to the 22% in group PROP [4]. The small differences
in results in these studies may in part reflect Sun’s
patients having a higher mean age than study group
PROP and/or random variation. Older patients have
an increased risk for hypothermia [9, 14, 15].
Without patient warming, temperature decreases can
continue for 3 h [16]. With the prompt initiation of
forced air warming, we found most of the redistribution
hypothermia occurred in the first 15 min. Within each
group, the differences in mean core temperature be-
tween T15 and T30, T30 and T45, and T45 and T60 were
small and clinically insignificant (Fig. 2).
We found a bolus dose of phenylephrine reduced
redistribution hypothermia. Ikeda et al. found intraop-
erative phenylephrine infusion decreased the magni-
tude of redistribution hypothermia [17]. Ikeda
concluded that even a short period of vasodilation
can result in redistribution hypothermia [3]. The
phenylephrine bolus opposed enough of the propofol
induced vasodilation to reduce the amount of redistri-
bution hypothermia. We administered a prior bolus
dose of phenylephrine (about 10 s before propofol)
without an infusion. Whether phenylephrine would be
as effective if given after the propofol is not known.
First, some vasodilation and heat transfer might have
already occurred, and second, it is unknown if there
is the same resultant vasodilation when phenylephrine
is given after propofol.
Techniques that can reduce redistribution
hypothermia now include prewarming [18–22], ketamine
[23], etomidate [24], phenylephrine infusions [17], amino
acid infusions [25], fructose [26], inhalation inductions
[3], and bolus phenylephrine prior to propofol. None of
these techniques solve the hypothermia problem fully.
Combinations of these techniques may result in add-
itional thermal benefit but have not been studied.
Inhalation inductions were performed gradually
(i.e., without a primed circuit) for two reasons. First,
apnea is unlikely to occur. Apnea never occurred in
the 100 inhalation patients. Second, gradually in-
creasing anesthetic depth likely contributes to
hemodynamic stability, a potential benefit of inhal-
ation inductions. Thwaites concluded that inhalation
inductions were more hemodynamically stable than
IV propofol inductions [27]. Retrospective studies
found that adverse outcomes were associated with
even short periods of hypotension, but not hyperten-
sion [28, 29]. Maheshwari et al. recently found that
a substantial fraction of all hypotension occurred be-
fore surgical incision as a result of anesthetic man-
agement; this hypotension was associated with
postoperative kidney injury [30]. We observed no
hypotension (systolic BP < 85 mmHg) in any inhal-
ation induction patient. Hypotension can occur rap-
idly with intravenous propofol inductions. Decreases
in blood pressure with inhalation inductions are
Table 2 Differences between the mean core temperature (°C) of each of three alternative induction groups and the standard
propofol alone group at each time point*
Comparison groups T15 T30 T45 T60
INH/100 minus PROP
Difference (°C) 0.46 0.46 0.47 0.49
95% CI of difference 0.28 to 0.64 0.28 to 0.64 0.25 to 0.69 0.20 to 0.77
INH/50 minus PROP
Difference (°C) 0.47** 0.52** 0.50 0.54
95% CI of difference 0.31 to 0.64 0.36 to 0.69 0.31 to 0.69 0.28 to 0.79
Phnl/PROP minus PROP
Difference (°C) 0.39 0.41 0.45 0.47**
95% CI of difference 0.24 to 0.54 0.25 to 0.57 0.27 to 0.63 0.25 to 0.70
*Applying Bonferroni’s correction for the 12 multiple comparisons (3 groups compared to propofol only group at 4 time points) results in α = 0.05/12 = 0.0042. All
12 comparisons achieved statistical significance as p ≤ 0.001 < α = 0.0042 for each of the above comparisons
**These differences are correct to 2 decimal places. Because of rounding to two decimal places in Fig. 2, they differ by 0.01 from those that would be calculated
using Fig. 2
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usually more gradual. Such gradual decreases could
be addressed earlier, or prophylactically, before there
is clinically important hypotension.
We found 160 mcg phenylephrine to be an effective
dose in most Phnl/PROP patients. Small percentages
of Phnl/PROP patients had a post-induction systolic
blood pressure either < 85 mmHg or > 180 mmHg. An
optimal phenylephrine dose (e.g., weight based) would
minimize hypotensive and hypertensive events and
still maintain the thermal benefit. We studied only
one dose of phenylephrine.
In the multivariable analysis, neither BMI nor sex
was associated with the degree of redistribution
hypothermia. This indicates that differences in BMI
and sex between treatment groups were not respon-
sible for the differences in mean core temperatures
(redistribution hypothermia) between groups. We
found patients were susceptible to redistribution
hypothermia regardless of BMI. Because it takes
more heat transfer to change the temperature of a
heavier patient, it is commonly believed that obese
patients are more resistant to temperature change.
However, a different process is dominant during the
initial redistribution hypothermia phase. Many obese
patients have substantial muscle mass in their per-
iphery to move their heavy body parts. The relatively
little blood flow in adipose tissue may prevent mean-
ingful temperature buffering during the redistribu-
tion hypothermia phase.
Limitations
We studied hypothermia during surgery, not surgical
outcome. Since hypothermia causes adverse outcomes
[1, 2], it is plausible that the studied alternative in-
duction techniques will result in superior clinical out-
comes than propofol by keeping patients warmer. It
remains to conduct randomized controlled trials ad-
dressing all major aspects of anesthesia care (e.g.,
hemodynamics, post-operative nausea and vomiting)
and whether clinical outcomes improve using any of
the alternative induction techniques.
Although our results suggest a possible hemodynamic
benefit of these alternative induction techniques, many
more patients need to be studied to demonstrate that
benefit.
In randomization, allocation of treatment to indi-
viduals is left purely to chance and not systematic-
ally biased by deliberate selection of patients.
Despite randomization, there were imbalances in sex
and BMI. These imbalances may have been due ei-
ther to chance or to insufficient group size. Increas-
ing the size of the study reduces the probability of
baseline differences in both measured and unmeas-
ured variables, but cannot assure balanced groups.
Baseline differences are only important if they affect
the study conclusions. In this study, these imbal-
ances did not provide an alternative explanation to
the three treatments’ thermal advantage over propo-
fol. In bivariate analyses, neither sex nor BMI were
associated with the observed temperature differences.
Their inclusion in the multivariable analysis did not
affect the temperature differences between propofol
and the other treatment groups, Thus, despite
baseline differences, neither sex nor BMI provides an
alternative explanation. Although there may be un-
measured confounding, the large and consistent dif-
ferences between propofol and the alternative
treatment groups makes it unlikely that the study
conclusions will change.
Although the study design reduced the risk of selec-
tion bias, the possibility of measurement bias still ex-
ists. Having one caregiver (the first author)
performing the randomization, providing anesthetic
care, and recording outcomes is a potential source of
bias. However, since the next study patient was
already in the operating room at the time of random
assignment, the caregiver could not affect the random
allocation. By having a single caregiver, the manner of
induction and all the tasks performed at the begin-
ning of the case were more uniform than if the tasks
were performed by multiple caregivers. The tempera-
tures recorded were objective and not affected by
who recorded the data.
We did not control for “depth of anesthesia”. A
greater depth of anesthesia likely results in more
vasodilation and thus more redistribution hypothermia
(and hypotension). If inductions achieve only the
minimum necessary depth, it is plausible there may
be less redistribution hypothermia (and hypotension).
In this effectiveness study, we titrated the mainten-
ance dose of anesthetic by vital signs, as is common
in clinical practice. Titrating anesthetic doses to
anesthetic depth may yield different results. A given
depth of anesthesia can be achieved by varying the
type and dose of anesthesia. We studied only one
dose of propofol. It is plausible that using a lower
dose of propofol and/or sevoflurane for induction will
result in less redistribution hypothermia. Kazama
et al. demonstrated that anesthetic inductions can be
accomplished with a smaller dose of propofol than
used in this study [31].
There were a variety of different surgeries, but no
major intraabdominal or intrathoracic surgeries (with
their greater potential for intraoperative heat loss).
Since patients with different surgeries were treated
similarly and had comparable thermal exposure in the
first 15 min post induction, the impact of the specific
surgery should be minor.
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We did not study intrathoracic or major intraab-
dominal surgeries where there is greater thermal
stress. We can make no statement as to whether the
initial thermal benefit is well maintained in such
cases.
We did not measure pre-induction (baseline) core
temperatures. Although studies similar to this one
often compare the changes from baseline temperature,
we did not. We measured the core temperatures at 4
times after induction. To address the lack of pre-test
core temperature measurements, we used a post-test
only randomized trial. Since the randomization makes
it likely that the baseline temperatures are similar in
the four groups, the observed post-induction differ-
ences are probably due to the different induction
techniques. Our experimental design, while less com-
mon, is a standard design that “contains no threats to
internal validity” [11].
We performed “as treated” analyses on 200 of the 205
(97.6%) randomized patients. Those 5 excluded patients
provided no valid temperature data. Four patients had
no post-induction temperature measurements because
they were withdrawn before T15. In one patient, there
was only one temperature measurement at T15. This pa-
tient received more than 300 mL unwarmed IV fluid.
This makes it very unlikely that the results differ sub-
stantially from an intention-to-treat analysis. With the
exclusion of these five patients, the 200 patients pre-
sented in Table 1 are exactly those we analyzed. Thus,
the randomization combined with the bivariate and
multivariable statistical results support the study conclu-
sion that the three alternative inductions produced
higher intraoperative temperatures than propofol alone.
Conclusions
This study makes evident the thermal benefits of
inhalation inductions and prophylactic bolus phenyl-
ephrine administration over standard intravenous pro-
pofol alone inductions in adults age 18 to 55
inclusive. This offers quick, simple, and easy to use
partial solutions to the on-going problem of intraop-
erative hypothermia.
Appendix 2
Table 4 Inclusion and exclusion criteria
Inclusion criteria
Age 18 to 55 years inclusive
Scheduled for general anesthesia where 50% nitrous oxide in
oxygen would be used
Endotracheal intubation or laryngeal mask airway insertion would be
used
Afebrile (preoperative oral or temporal scan temperature between
36.2 and 37.4 °C inclusive)
Positioned supine or lithotomy
Forced air warming would be used
Expected duration of anesthetic to be at least 60 min
Exclusion criteria
Emergency surgery or any other aspiration risk
Age < 18 years or > 55 years
Pregnant
Incarceration
Febrile illness
Anticipated difficult airway
Contraindication to nitrous oxide use
Contraindication to nasal instrumentation
Nasal surgery
Current or recent epistaxis
Requirement for foreign language interpreter
Allergy to propofol
Malignant hyperthermia risk
Inability to oxygenate on less than 50% oxygen
Cardiac surgery
Neuro-surgery
Receiving vasoactive infusions
Significant valvular heart disease
Unstable cardiac disease
Requiring prone or lateral positioning
Inability to provide informed consent
Inability to use forced air warming
Untreated hypo- or hyper-thyroidism
ASA class 4, 5 or 6a
Anticipated inability to tolerate any of the 4 different anesthetic
induction options in this study
aPatients with end stage renal disease on dialysis were classified as ASA 3
Appendix 1
Table 3 Study groups
Group Induction technique
INH/100 Inhalation: 8% sevoflurane in 100% oxygen
INH/50 Inhalation: 8% sevoflurane in 50% oxygen and 50%
nitrous oxide
PROP Intravenous: 2.2 mg propofol
Phyl/PROP Intravenous: 2.2 mg propofol preceded by 160 mcg
phenylephrine
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Abbreviations
BMI: Body mass index; BP: Blood pressure; C: Centigrade; CI: Confidence
interval; FAW: Forced air warming; Hg: Mercury; INH/100: Study group
induced with 100% oxygen; INH/50: Study group induced with 50% oxygen
and 50% nitrous oxide; IV: Intravenous; kg: Kilogram; LMA: Laryngeal mask
airway; LPM: Liters per minute; m: Meter; mcg: Microgram; mg: Milligram;
mL: Milliliter; mm: Millimeter; N2O: Nitrous oxide; O2: Oxygen; Phnl/
PROP: Study group induced with 160 mcg phenylephrine followed by 2.2
mg/kg IV propofol; PROP: Study group induced with 2.2 mg/kg IV propofol;
SCIP: Surgical Care Improvement Project; SD: Standard deviation; Tx: Time x
minutes after the start of anesthetic induction
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Appendix 3
Table 5 List of surgeries
Procedure Groups having at least one patient having the listed procedure are denoted by an
x
INH/100 INH/50 PROP Phnl/PROP
UROLOGIC
Cystoscopic surgery x x x x
Penile procedures x x x
Suprapubic tube placement x
Scrotal procedures x
Urethroplasty x x x
ORTHOPEDIC
Lower extremity orthopedics x x x x
Upper extremity orthopedics x x x x
Anterior cervical discectomy and fusion x
GYNECOLOGIC
Vulvoplasty or excision of lesion x x
Dilation and curettage, hysteroscopy x x x x
Loop endocervical excision procedure x x
Endocervical curettage x x
Hysterectomy x x x
Myomectomy x x x
VASCULAR
Dialysis access related procedures x x x x
Lower extremity vascular – open procedures x
Radiofrequency ablation and/or Lower extremity phlebectomies x x x
Lower extremity amputations x x
DENTAL/ENT x x x
THORACIC
Endobronchial ultrasound x x x
GENERAL SURGERY
Vacuum assisted closure change x
Non-cavitary procedures x x x
Inguinal hernia x x
Breast x x x x
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